↓ Skip to main content

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria

Overview of attention for article published in Scientific Reports, August 2017

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
12 X users
patent
1 patent

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria
Published in
Scientific Reports, August 2017
DOI 10.1038/s41598-017-07246-0
Pubmed ID
Authors
Abstract

The majority of routinely given vaccines require two or three immunisations for full protective efficacy. Single dose vaccination has long been considered a key solution to improving the global immunisation coverage. Recent infectious disease outbreaks have further highlighted the need for vaccines that can achieve full efficacy after a single administration. Viral vectors are a potent immunisation platform, benefiting from intrinsic immuno-stimulatory features while retaining excellent safety profile through the use of non-replicating viruses. We investigated the scope for enhancing the protective efficacy of a single dose adenovirus-vectored malaria vaccine in a mouse model of malaria by co-administering it with vaccine adjuvants. Out of 11 adjuvants, only two, Abisco(®)-100 and CoVaccineHT(TM), enhanced vaccine efficacy and sterile protection following malaria challenge. The CoVaccineHT(TM) adjuvanted vaccine induced significantly higher proportion of antigen specific central memory CD8(+) cells, and both adjuvants resulted in increased proportion of CD8(+) T cells expressing the CD107a degranulation marker in the absence of IFNγ, TNFα and IL2 production. Our results show that the efficacy of vaccines designed to induce protective T cell responses can be positively modulated with chemical adjuvants and open the possibility of achieving full protection with a single dose immunisation.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Master 7 15%
Student > Bachelor 6 13%
Student > Ph. D. Student 5 11%
Researcher 4 9%
Other 3 7%
Other 4 9%
Unknown 17 37%
Readers by discipline
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 13%
Medicine and Dentistry 6 13%
Agricultural and Biological Sciences 5 11%
Immunology and Microbiology 4 9%
Veterinary Science and Veterinary Medicine 1 2%
Other 4 9%
Unknown 20 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 December 2022.
All research outputs
#4,792,195
of 33,979,905 outputs
Outputs from Scientific Reports
#40,256
of 181,929 outputs
Outputs of similar age
#63,909
of 356,386 outputs
Outputs of similar age from Scientific Reports
#1,450
of 6,314 outputs
Altmetric has tracked 33,979,905 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 181,929 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.1. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,386 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 6,314 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.